Skip to main content
Clinical Trials/ACTRN12622001215718
ACTRN12622001215718Not yet recruiting未知

Feasibility of novel endoscopic imaging techniques during transbronchial lung biopsy in interstitial lung disease

Royal Melbourne Hospital0 sites20 target enrollmentStarted: September 9, 2022Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Not yet recruiting
Enrollment
20

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Non-randomised trial
Primary Purpose
Diagnosis
Masking
Open (masking not used)

Eligibility Criteria

Ages
18 Years to o limit (—)
Sex
All

Inclusion Criteria

  • Adults aged 18 years or older
  • - Working diagnosis of unclassifiable interstitial lung disease or a low confidence diagnosis
  • - Referred for cryobiopsy following discussion at an ILD multidisciplinary meeting

Exclusion Criteria

  • Reduced lung function (FVC less than 50% predicted; or FEV1 less than 50% predicted or less than 0.8L; or DLCO less than 50% predicted or less than 35 units)
  • Uncontrolled bleeding diathesis
  • American Society of Anesthesiology Status of III or higher
  • Hypoxaemia (PaO2 less than 55 to 60mmHg on room air or while receiving 2L/minute nasal oxygen)
  • Pulmonary hypertension (sPAP greater than 50mmHg)
  • Body mass index greater than 35kg/m2
  • Inability to give informed consent
  • Vulnerable population (inability to understand English, pregnant women, prisoner)

Investigators

Similar Trials